Curis
CRIS
#10252
Rank
A$33.26 M
Marketcap
A$0.83
Share price
-2.15%
Change (1 day)
-67.42%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -A$50.91 Million

According to Curis's latest financial reports the company's current earnings are A$11.65 Million. In 2024 the company made an earning of -A$59.8 Million, an increase over its 2023 earnings that were of -A$63.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$50.91 Million-14.87%
2024 -A$59.8 Million-5.77%
2023 -A$63.47 Million-13.1%
2022 -A$73.03 Million27.52%
2021 -A$57.27 Million65.09%
2020 -A$34.69 Million-9.1%
2019 -A$38.16 Million-4.73%
2018 -A$40.06 Million-41.95%
2017 -A$69 Million-14.37%
2016 -A$80.58 Million3.55%
2015 -A$77.81 Million271.52%
2014 -A$20.95 Million76.64%
2013 -A$11.86 Million
2011 -A$10.07 Million27.76%
2010 -A$7.89 Million-43.87%
2009 -A$14.05 Million-23.44%
2008 -A$18.35 Million56.66%
2007 -A$11.71 Million-16.71%
2006 -A$14.06 Million-36.92%
2005 -A$22.29 Million156.25%
2004 -A$8.7 Million-37.24%
2003 -A$13.86 Million-93.34%
2002 -A$0.21 Billion86.79%
2001 -A$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.24 B-31,404.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.04 B-28,750.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$86.51 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.31 B-2,990.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.41 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$34.62 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA